|
Projets(s) de recherche, responsable |
|
|
Anatomically relevant brachytherapy implants by a 3D printing and radiosenstizing approach, Marc-André Fortin
|
|
|
A Randomized Trial of Regional Radiotherapy in Luminal A Breast Cancer, Valérie Théberge
|
|
|
Biochemical and structural studies of poly-TPR containing proteins involved in epigenetic signalling, Amélie Fradet-Turcotte
|
|
|
Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays., Jacques Simard
|
|
|
Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy, Francine Durocher
|
|
|
Decoding the DNA double-strand break repair pathways: from mechanistic insights to human genome instability diseases, Jean-Yves Masson
|
|
|
Developing synthetic S100A9-based molecules for differentiation therapy of human acute myeloid leukemia, Philippe Tessier
|
|
|
Effect of environmental contaminants and methylome of breast adipose tissue on aromatase inhibitor efficacy in breast cancer, Caroline Diorio
|
|
|
Emerging roles of Zinc Finger PAR-Interacting Proteins (ZIPPs) in DNA double-strand break (DSB) repair: implications in PARPi therapy, Guy Poirier
|
|
|
Implantation d'un registre de données au sein des cliniques de traitement de la douleur du Québec
|
|
|
Mechanism of Ribosomal RNA Gene Silencing and Its Roles in Pluripotency and Cancer, Thomas Moss
|
|
|
Omega-3 fatty acids in the prevention of breast cancer: role of obesity-related markers in breast tissues, Caroline Diorio
|
|
|
Pre-clinical pharmacokinetic and efficacy assays with an efficient 17beta-hydroxysteroid dehydrogenase type 7 inhibitor for breast cancer therapy, Sheng-Xiang Lin
|
|
|
Role and regulation of EPB41L5 in cancer-promoting cellular processes, Patrick Laprise
|
|
|
Role of MYST-ING acetyltransferase complexes in transcription regulation, cell fate and disease, Jacques Côté
|
|
|
Role of the RAS Pathway Activation on the Biology and Drug Response of Acute Myeloid Leukemias, Frédéric Barabé
|
|
|
Targeting sex steroids to improve the response to bladder cancer immunotherapy, Paul Toren
|
|
|
The BUBR1 pseudokinase in Spindle Checkpoint Activation and Inactivation, Sabine Elowe
|
|
|
The impact of Monte Carlo dose calculations on prostate and breast low-dose rate brachytherapy dose-outcome relationships and radiobiological modeling, Luc Beaulieu
|
|
|
The Ribosomal RNA Genes in Growth, Pluripotency, Senescence and Cancer, Thomas Moss
|
|
|
Understanding mitochondrial metabolism to identify prostate cancer metabolic vulnerabilities, Étienne Audet-Walsh
|
|
|
Unraveling the molecular mechanisms that promote replication stress and resistance to chemoradiation in oropharyngeal cancer caused by human papillomavirus, Amélie Fradet-Turcotte
|
|
|
Unravelling the role of primary cilia in prostate cancer initiation and progression, Clémence Belleannée
|